ATE358136T1 - Prionen-bindende peptidsequenzen - Google Patents
Prionen-bindende peptidsequenzenInfo
- Publication number
- ATE358136T1 ATE358136T1 AT02779505T AT02779505T ATE358136T1 AT E358136 T1 ATE358136 T1 AT E358136T1 AT 02779505 T AT02779505 T AT 02779505T AT 02779505 T AT02779505 T AT 02779505T AT E358136 T1 ATE358136 T1 AT E358136T1
- Authority
- AT
- Austria
- Prior art keywords
- peptide sequences
- binding peptide
- prion binding
- prp
- prion protein
- Prior art date
Links
- 102000029797 Prion Human genes 0.000 title abstract 3
- 108091000054 Prion Proteins 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 102000001708 Protein Isoforms Human genes 0.000 abstract 1
- 108010029485 Protein Isoforms Proteins 0.000 abstract 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2002/011868 WO2004037854A1 (en) | 2002-10-23 | 2002-10-23 | Prion protein-binding peptide sequences |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE358136T1 true ATE358136T1 (de) | 2007-04-15 |
Family
ID=32116206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02779505T ATE358136T1 (de) | 2002-10-23 | 2002-10-23 | Prionen-bindende peptidsequenzen |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1554305B1 (de) |
| AT (1) | ATE358136T1 (de) |
| AU (1) | AU2002342850A1 (de) |
| DE (1) | DE60219215T2 (de) |
| DK (1) | DK1554305T3 (de) |
| ES (1) | ES2283608T3 (de) |
| PT (1) | PT1554305E (de) |
| WO (1) | WO2004037854A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2535261C (en) | 2003-08-13 | 2015-11-24 | Chiron Corporation | Prion-specific peptide reagents |
| NZ594844A (en) | 2005-09-09 | 2013-04-26 | Novartis Ag | Prion-specific peptoid reagents |
| WO2008018795A1 (en) | 2006-08-11 | 2008-02-14 | Prosensa Technologies B.V. | Methods and means for treating dna repeat instability associated genetic disorders |
| DK2167136T3 (en) | 2007-07-12 | 2016-07-25 | Biomarin Tech Bv | Molecules for targeting compounds at different selected organs or tissues |
| NZ584793A (en) | 2007-10-26 | 2012-05-25 | Academisch Ziekenhuis Leiden | Means and methods for counteracting muscle disorders |
| USRE48468E1 (en) | 2007-10-26 | 2021-03-16 | Biomarin Technologies B.V. | Means and methods for counteracting muscle disorders |
| EP2119783A1 (de) | 2008-05-14 | 2009-11-18 | Prosensa Technologies B.V. | Verfahren für effizientes Exon (44)-Skipping bei Duchenne-Muskeldystrophie und entsprechende Mittel |
| JP2012524540A (ja) | 2009-04-24 | 2012-10-18 | プロセンサ テクノロジーズ ビー．ブイ． | Ｄｍｄを処置するためのイノシンを含むオリゴヌクレオチド |
| EP2806900B1 (de) | 2012-01-27 | 2021-12-15 | BioMarin Technologies B.V. | Rna-modulierende oligonukleotide mit verbesserten eigenschaften zur behandlung der duchenne- und becker-muskeldystrophie |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998055132A1 (en) * | 1997-06-02 | 1998-12-10 | The Regents Of The University Of California | Prion protein modulator factor (ppmf) and prion resistant animals |
| GB9823835D0 (en) * | 1998-10-30 | 1998-12-23 | Univ London | Component for vaccine |
| US6399575B1 (en) * | 1998-11-10 | 2002-06-04 | Auburn University | Methods and compositions for targeting compounds to the central nervous system |
| EA200100264A1 (ru) * | 1999-06-21 | 2001-10-22 | Филадельфия Хеалс Энд Эдьюкейшн Корпорейшн | Ангиоцидин: адгезионный рецептор опухолей клетки, специфический для cys-ser-val-thr-cys-gly |
| CA2449412C (en) * | 2000-11-30 | 2013-04-02 | Uab Research Foundation | Receptor-mediated uptake of peptides that bind the human transferrin receptor |
| JP2005501220A (ja) * | 2000-12-19 | 2005-01-13 | パラチン テクノロジーズ インク． | ペプチドおよび蛋白質の標的特異的折りたたみ部位の識別 |
-
2002
- 2002-10-23 DK DK02779505T patent/DK1554305T3/da active
- 2002-10-23 DE DE60219215T patent/DE60219215T2/de not_active Expired - Fee Related
- 2002-10-23 ES ES02779505T patent/ES2283608T3/es not_active Expired - Lifetime
- 2002-10-23 AU AU2002342850A patent/AU2002342850A1/en not_active Abandoned
- 2002-10-23 PT PT02779505T patent/PT1554305E/pt unknown
- 2002-10-23 WO PCT/EP2002/011868 patent/WO2004037854A1/en active IP Right Grant
- 2002-10-23 AT AT02779505T patent/ATE358136T1/de not_active IP Right Cessation
- 2002-10-23 EP EP02779505A patent/EP1554305B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1554305B1 (de) | 2007-03-28 |
| EP1554305A1 (de) | 2005-07-20 |
| DE60219215D1 (de) | 2007-05-10 |
| AU2002342850A1 (en) | 2004-05-13 |
| ES2283608T3 (es) | 2007-11-01 |
| DK1554305T3 (da) | 2007-04-23 |
| DE60219215T2 (de) | 2008-01-03 |
| AU2002342850A8 (en) | 2004-05-13 |
| WO2004037854A1 (en) | 2004-05-06 |
| PT1554305E (pt) | 2007-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124802T1 (el) | Δεσμευτικοι παραγοντες σκληροστινης | |
| GB2433936A (en) | Therapeutic peptides comprising sequences derived from CDR2 or CDR3 of trem-1 and uses thereof to inhibit sepsis | |
| DE602004006433D1 (de) | Pyrrol-substituierte indole als inhibitoren von pai-1 | |
| CY1111225T1 (el) | Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c | |
| MA32982B1 (fr) | Proteines de liaison au recepteur cgrp humain | |
| IL232501A (en) | Peptide or polypeptide-resistant protein analogs and their uses | |
| BRPI0517973A (pt) | método para purificar o fsh | |
| WO2006023844A3 (en) | Compositions and methods comprising proteinase activated receptor antagonists | |
| NO20063064L (no) | Ny anvendelse av peptidforbindelser for behandling av sentralneurotisk smerte | |
| NO20090624L (no) | Forbindelser som modulerer CB2 receptoren | |
| GEP20115324B (en) | Tweak binding antibodies | |
| WO2003100033A3 (en) | ANTI-αvβ6 ANTIBODIES | |
| MX2009012949A (es) | Anticuerpos humanizados que enlazan a ab (1-42) globulomero y usos de los mismos. | |
| TW200724140A (en) | Hydantoin compounds | |
| EA200801180A1 (ru) | Селективные пептидные агонисты рецептора vpac2 | |
| CY1112673T1 (el) | Φαινοξυ αιθερες αμινοξεων | |
| MX2008000230A (es) | Proteinas de enlace il-6. | |
| WO2006019982A3 (en) | Pin1-modulating compounds and methods of use thereof | |
| NO20083050L (no) | Forbindelser og fremgangsmater for hemming av interaksjon av Bcl-proteiner med bindingspartnere | |
| WO2004002418A3 (en) | Compositions and methods comprising protein activated receptor antagonists | |
| DK1554305T3 (da) | Prionprotein-bindende peptidsekvenser | |
| DE50013435D1 (de) | Peptide gegen dcm hervorrufende autoantikörper | |
| DE60207043D1 (de) | Histidine-rich glycoprotein (hrgp) zur hemmung der angiogenese | |
| ATE247130T1 (de) | Inhibitoren für den urokinaserezeptor | |
| UA87117C2 (ru) | Применение пептидных соединений для лечения центральной невропатической боли |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1554305 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |